The Public Health Department has reported three new suspected cases of Guillain-Barré Syndrome (GBS) on Sunday, bringing the ...
The U.S. Food and Drug Administration (FDA) created a major media stir last week when it announced the approval of suzetrigine (brand name Journavx), a unique new non-opioid, non-addictive drug for ...